We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024
25 Apr 2024 - 27 Apr 2024

PCR-Based Molecular Platform to Enable Drastically Faster Bacterial Infection Diagnosis

By LabMedica International staff writers
Posted on 08 Jun 2023
Print article
Image: Molecular Culture® technique enables drastically faster and more accurate bacterial diagnostics (Photo courtesy of inbiome)
Image: Molecular Culture® technique enables drastically faster and more accurate bacterial diagnostics (Photo courtesy of inbiome)

A new novel PCR-based molecular platform provides a significant advancement in diagnosing bacterial infections by offering an alternative to traditional culture methods and outperforming newer methods such as sequencing on the time and cost front, while also matching the scope of other PCR tests.

Inbiome’s (Amsterdam, the Netherlands) Molecular Culture technique significantly speeds up and improves the precision of bacterial diagnostics compared to traditional culture. This revolutionary diagnostic technique has the capability to identify the vast majority of bacterial species through a single test. It is particularly tailored to deliver accurate results from invasively collected samples, such as cerebrospinal fluid, pus, and joint aspirates. Unlike culture or traditional PCR-based methods, Molecular Culture is not selective, which means medical professionals don't need to decide in advance which bacteria to search for. Since it is based on DNA detection, it can easily identify or detect bacteria that are unknown, uncultivable or have been treated with antibiotics.

Compared to conventional tests, Molecular Culture is more sensitive and precise. It accurately diagnoses almost double the number of positive samples, significantly reducing the prevalence of false negatives often associated with traditional testing. This leads directly to more informed treatment decisions, consequently improving patient outcomes. Moreover, the diagnostic process is quick, efficient, and simple. It delivers reliable and actionable results within four hours without the need for specialized equipment or bioinformatics pipelines. This means patients recover more quickly, complications are minimized, and the duration of hospital stays is substantially reduced. Currently, Molecular Culture is being utilized in several hospitals in the Netherlands, demonstrating exceptional results.

Related Links:
inbiome

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: ‘Virtual biopsy’ allows clinicians to analyze skin noninvasively (Photo courtesy of Stanford Medicine)

Virtual Skin Biopsy Determines Presence of Cancerous Cells

When dermatologists spot an unusual mark on a patient's skin, they face a choice: monitor it for some time or remove it for biopsy. Similarly, when removing breast tumors, surgeons must send excised tissues... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.